1. From the Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Germany (T.S., S.M.K., N.H., F.H., D.N.M., M.B., M.S., R.D., K.K., M.G.);
2. Institute of Pharmacology, Berlin, Germany (T.S., M.S.);
3. Berlin Institute of Health, Germany (T.S., S.M.K., N.H., F.H., N.A., D.N.M., M.B., M.S., R.D., K.K., M.G.);
4. German Center for Cardiovascular Research, Partner Site Berlin, Germany (T.S., S.M.K., N.H., A. Birukov, N.A., D.N.M., M.B., R.D., K.K., M.G.);
5. Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (S.M.K., N.H., F.H., N.A., D.N.M., M.B., R.D., K.K., M.G.);
6. Experimental and Clinical Research Center—a joint cooperation between the Max-Delbrück-Center for Molecular Medicine and the Charité–Universitätsmedizin Berlin, Germany (S.M.K., N.H., F.H., A. Birukov, D.N.M., R.D., K.K., M.G.);
7. HealthTwiSt GmbH, Berlin, Germany (A. Busjahn);
8. Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany (A. Birukov);
9. German Center for Diabetes Research, München-Neuherberg, Germany (A. Birukov);
10. Institute for Biology, University of Lübeck, Germany (M.B.);